SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    Tesh R.B. (1982) Arthritides caused by mosquito-borne viruses. Annu Rev Med 33: 3140.
  • 2
    Volk S.M., Chen R., Tsetsarkin K.A., Adams A.P., Garcia T.I., Sall A.A., Nasar F., Schuh A.J., Holmes E.C., Higgs S., Maharaj P.D., Brault A.C., Weaver S.C. (2010) Genome-scale phylogenetic analysis of chikungunya virus reveal independent emergences of recent epidemics and various evolutionary rates. J Virol 84(13): 6497504.
  • 3
    Simon F., Javelle E., Oliver M., Leparc-Goffart I., Marimoutou C. (2011) Chikungunya virus infection. Curr Infect Dis Rep 13(3): 21828.
  • 4
    LaBaeva A.D., Bashir F., King C.H. (2011) Measuring the burden of arboviral diseases: the spectrum of morbidity and mortality from four prevalent infections. Popul Health Metr 9(1): 516.
  • 5
    Gerardin P., Fianu A., Malvy D., Mussard C., Boussaid K., Rollot O., Michault A., Gaüzere B.A., Bréart G., Favier F. (2011) Perceived morbidity and community burden after a chikungunya outbreak: the TELECHIK survey, a population-based cohort study. BMC Medicine 9: 516.
  • 6
    Simon F., Parola P., Grandadam M., Fourcade S., Oliver D.F.M., Brouqui P., Hance P., Kraemer P., Ali Mohamed A., de Lamballerie X., Charrel R., Tolou H. (2007) Chikungunya infection: an emerging rheumatism among travelers returned from Indian Ocean islands: report of 47 cases. Medicin (Baltimore) 86(3): 12337.
  • 7
    Sissoko D., Malvy D., Ezzedine K., Renault P., Moscetti F., Ledrans M., Pierre V. (2009) Post-epidemic chikungunya disease on Reunion Island: course of rheumatic manifestations and associated factors over a 15-month period. PLoS Negl Trop Dis 3(3): e389.
  • 8
    Bouquillard E., Combe B. (2009) A report of 21 cases of rheumatoid arthritis following chikungunya fever. A mean follow-up of 2 years. Joint Bone Spine 76(6): 6547.
  • 9
    Das T., Jaffar-Bandjee M.C., Hoarau J.J., Krejbich T.P., Denizot M., Lee-Pat-Yuen G., Sahoo R., Guiraud P., Ramful D., Robin S., Alessandri J.L., Gauzere B.A., Gasque P. (2010) Chikungunya fever: CNS infection pathologies of a re-emerging arbovirus. Prog Neurobiol 91(2): 1219.
  • 10
    Lewthwaite P., Vasanthapuram R., Osborn J.C., Begum A., Plank J.L., Shankar M.V., Hewson R., Desai A., Beeching N.J., Ravikumar R., Solomon T. (2009) Chikungunya virus and central nervous system infections in children, India. Emerg Infect Dis 15(2): 32931.
  • 11
    Hoarau J-J., Bandjee M-C. J., Trotot P.K., Das T., Li-Pat-Yuen G., Dassa B., Denizot M., Guichard E., Ribera A., Henni T., Tallet F., Moiton M.P., Gauzère B.A., Bruniquet S., Jaffar Bandjee Z., Morbidelli P., Martigny G., Jolivet M., Gay F., Grandadam M, Tolou H., Vieillard V., Debré P., Autran B., Gasque P. (2010) Persistent chronic inflammation and infection by chikungunya arthritogenic alphavirus in spite of a robust host immune response. J Immunol 184(10): 591427.
  • 12
    Ng L.F.P., Chow A., Sun Y-J., Kwek D.J.C., Lim P-L., Dimatatac F., Ng L.C., Ooi E.E., Choo K.H., Her Z., Kourilsky P., Leo Y.S. (2009) IL-1β, IL-6, and RANTES as biomarkers of chikungunya severity. PLoS One 4(1): e42618.
  • 13
    Chow A., Her Z., Ong E.K.S., Chen J-M., Dimatatac F., Kwek D.J., Barkham T., Yang H., Rénia L., Leo Y.S., Ng L.F. (2011) Persistent arthralgia induced by chikungunya virus infection in associated with interleukin-6 and granulocyte macrophage colony-stimulating factor. J Infect Dis 203(2): 14957.
  • 14
    Win M.K., Chow A., Dimatatac F., Go C.J., Leo Y.S. (2010) Chikungunya in Singapore: acute clinical and laboratory features, and factors associated with persistent arthralgia. J Clin Virol 49(2): 1114.
  • 15
    Staikowsky F., Talarmin F., Grivord P., Souab A., Schuffenecker I., Le Roux K., Lecuit M., Michault A. (2009) Prospective study chikungunya virus acute infection in the island of La Reunion during the 2005–2006 outbreak. PLOS One 4(10): e760311.
  • 16
    Olivadoti M.D., Opp M.R. (2008) Effects of i.v. administration of interleukin-1 on sleeps and body temperature of interleukin -6 deficient mice. Neuroscience 153(1): 33848.
  • 17
    Redlich K., Schett G., Steiner G., Hayer S., Wagner E.F., Smolen J.S. (2003) Rheumatoid arthritis therapy after tumor necrosis factor and interleukin-1 blockade. Arthritis Rheum 48(12): 330819.
  • 18
    Moller B., Villiger P.M. (2006) Inhibition of IL-1, IL-6 and TNF-α in immune-mediated inflammatory diseases. Springr Semin Immunopathol 27(4): 391408.
  • 19
    Ferraccioli G., Bracci-Laudiero L., Alivernini S., Gremese E., Tolusso B., de Benedetti F. (2010) Interleukin-1β and interleukin-6 in arthritis animal models: roles in the early phase of transition from acute to chronic inflammation and relevance for human rheumatoid arthritis. Mol Med 16(11–12): 5527.
  • 20
    Kimura A., Kishimoto T. (2010) IL-6: regulator of Treg/Th17 balance. Eur J Immunol 40(7): 18305.
  • 21
    Gaffen S.L. (2009) Role of IL-17 in the pathogenesis of rheumatoid arthritis. Curr Rheumatol Rep 11(5): 36570.
  • 22
    Koenders M.I., Marijinissen R.J., Devesa I., Lubbert E., Joosten L.A.B., Roth J., van Lent L.E.M.P., van de Loo F.A., van den Berg W.B. (2011) TNF/IL17 interplay induces S100A8, IL-1β and MMPs and drives irreversible cartilage destruction in vivo: rationale for combination treatment during arthritis. Arthritis Rheum. doi: 10.1002/art.30418.
  • 23
    Schaible H.G., von Banchet G.S., Boettqer M.K., Bräuer R., Gajda M., Richter F., Hensellek S., Brenn D., Natura G. (2010) The role of proinflammatory cytokines in the generation and maintenance of joint pain. Ann NY Acad Sci 1193: 609.
  • 24
    Graves D.T., Valente A.J. (1991). Monocyte chemotactic proteins from human tumor cells. Biochem Pharmacol 41(3): 3337.
  • 25
    Labadie K., Larcher T., Joubert C., Mannioui A., Delache B., Brochard P., Guigand L., Dubreil L., Lebon P., Verrier B., de Lamballerie X., Suhrbier A., Cherel Y., Le Grand R., Roques P. (2010) Chikungunya disease in nonhuman primates involves long-term viral persistence in macrophages. J Clin Invest 120(3): 894906.
  • 26
    Gardner J., Anraku I., Le T.T., Larcher T., Major L., Roques P., Schroder W.A., Higgs S., Suhrbier A. (2010) Chikungunya virus arthritis in adult wild-type mice. J Virol 84(16): 802132.
  • 27
    Rulli N.E., Rolph M.S., Srikiatkhachorn A., Anantapreecha S., Guglielmotti A., Mahalingam S. (2011). Protection from arthritis and myositis in a mouse model of acute chikungunya virus disease by Bindarit, an inhibitor of monocyte chemotactic protein-1 synthesis. J Infect Dis 204(7): 102630.
  • 28
    Morrison T.E., Whitemore A.C., Shabman R.S., Lidbury B.A., Mahalingam S., Heise M.T. (2006) Characterization of Ross River Virus tropism and virus-induced inflammation in a mouse model of viral arthritis and myositis. J Virol 80(2): 73749.
  • 29
    Lidbury B.A., Rulli M.E., Suhrbier A., Smith P.N., McColl S.R., Cunningham A.L, Tarkowski A., van Rooijen N., Fraser R.J., Mahalingam S. (2008) Macrophage-derived proinflammatory factors contribute to the development of arthritis and myositis after infection with an arthrogenic alphavirus. J Infect Dis 197(11): 158593.
  • 30
    Rulli N.E., Guglielmotti A., Mangano G., Rolph M.S., Apicella C., Zaid A., Suhrbier A., Mahalingam S. (2009) Amelioration of alphavirus induced arthritis and myositis in a mouse model by treatment with bindarit, an inhibitor of monocyte chemotactic proteins. Arthritis Rheum 60(8): 251323.
  • 31
    Kelvin A.A., Banner D., Silvi G., Moro M.L., Spataro N., Gaibani P., Cavrini F., Pierro A., Rossini G., Cameron M.J., Bermejo-Martin J.F., Paquette S.G., Xu L., Danesh A., Farooqui A., Borghetto I., Kelvin D.J., Sambri V., Rubino S. (2011). Inflammatory cytokine expression is associated with chikungunya virus resolution and symptom severity. Plos Neg Trop Dis 5(8): e127990.
  • 32
    Rollenhagen C., Asin S.N. (2010) IL-8 decreases HIV-1 transcription in peripheral blood lymphocytes and ectocervical tissue explants. J Acquir Immune Defic Syndr 54(5): 4639.
  • 33
    Lunney J.K., Fritz E.R., Reecy J.M., Kuhar D., Pruenal E., Molina R., Christopher-Hennings J., Zimmerman J., Rowland R.R. (2010) Interleukin-8, interleukin-1beta, and interferon-gamma levels are linked to PRRS virus clearance. Viral Immunol 23(2): 12734.
  • 34
    Her Z, Malleret B., Chan M., Ong E.K., Wong S.C., Kwek D.J., Tolou H., Lin R.T., Tambyah P.A., Rénia L., Ng L.F. (2010) Active infection of human blood monocytes by Chikungunya virus triggers an innate immune response. J Immunol 184(10): 590313.